Medical device development for children and young people—reviewing the challenges and opportunities

DIMITRI, Paul, PIGNATARO, Valeria, LUPO, Mariangela, BONIFAZI, Donato, HENKE, Maria, MUSAZZI, Umberto M., ERNST, Floris, MINGHETTI, Paola, REDAELLI, Davide F., ANTIMISIARIS, Sophia G., MIGLIACCIO, Giovanni, BONIFAZI, Fedele, MARCIANI, Luca, COURTENAY, Aaron J., DENORA, Nunzio and LOPEDOTA, Angela (2021). Medical device development for children and young people—reviewing the challenges and opportunities. Pharmaceutics, 13 (12).

[img]
Preview
PDF
pharmaceutics-13-02178.pdf - Published Version
Creative Commons Attribution.

Download (1MB) | Preview
Official URL: https://www.mdpi.com/1999-4923/13/12/2178
Open Access URL: https://www.mdpi.com/1999-4923/13/12/2178/pdf (Published version)
Link to published version:: https://doi.org/10.3390/pharmaceutics13122178
Related URLs:

    Abstract

    Development of specific medical devices (MDs) is required to meet the healthcare needs of children and young people (CYP). In this context, MD development should address changes in growth and psychosocial maturation, physiology, and pathophysiology, and avoid inappropriate repurposing of adult technologies. Underpinning the development of MD for CYP is the need to ensure MD safety and effectiveness through pediatric MD-specific regulations. Contrary to current perceptions of limited market potential, the global pediatric healthcare market is expected to generate around USD 15,984 million by 2025. There are 1.8 billion young people in the world today; 40% of the global population is under 24, creating significant future healthcare market opportunities. This review highlights a number of technology areas that have led to successful pediatric MD, including 3D printing, advanced materials, drug delivery, and diagnostic imaging. To ensure the targeted development of MD for CYP, collaboration across multiple professional disciplines is required, facilitated by a platform to foster collaboration and drive innovation. The European Pediatric Translational Research Infrastructure (EPTRI) will be established as the European platform to support collaboration, including the life sciences industrial sector, to identify unmet needs in child health and support the development, adoption, and commercialization of pediatric MDs.

    Item Type: Article
    Additional Information: ** From MDPI via Jisc Publications Router ** Licence for this article: https://creativecommons.org/licenses/by/4.0/ **Journal IDs: eissn 1999-4923 **History: published 17-12-2021; accepted 02-12-2021
    Uncontrolled Keywords: medical devices, pediatrics, 3D printing, diagnostic imaging, delivery device, patient involvement
    Identification Number: https://doi.org/10.3390/pharmaceutics13122178
    SWORD Depositor: Colin Knott
    Depositing User: Colin Knott
    Date Deposited: 20 Dec 2021 16:17
    Last Modified: 20 Dec 2021 16:17
    URI: http://shura.shu.ac.uk/id/eprint/29464

    Actions (login required)

    View Item View Item

    Downloads

    Downloads per month over past year

    View more statistics